Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy
Ying Zhang, Yunjie Ge, Xiaohui Wu, Shuangmei LiuDepartment of Internal Medicine, Municipal Hospital, Qingdao, Shandong, People’s Republic of ChinaAbstract: The prevalence of cancer remains high. With the improvement of diagnosis and treatment level and the increase of cancer survivors afte...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-treatment-of-advanced-synchronous-triple-primary-malignancies-peer-reviewed-article-OTT |
id |
doaj-20366fa36d574350b1b8acea3a26ed46 |
---|---|
record_format |
Article |
spelling |
doaj-20366fa36d574350b1b8acea3a26ed462020-11-25T01:49:05ZengDove Medical PressOncoTargets and Therapy1178-69302019-04-01Volume 122421243044887Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapyZhang YGe YWu XLiu SYing Zhang, Yunjie Ge, Xiaohui Wu, Shuangmei LiuDepartment of Internal Medicine, Municipal Hospital, Qingdao, Shandong, People’s Republic of ChinaAbstract: The prevalence of cancer remains high. With the improvement of diagnosis and treatment level and the increase of cancer survivors after treatment, multiple primary tumors are more common than before. The diagnosis and treatment of synchronous multiple primary tumors is more complicated than that of single or metachronous multiple tumors, and patients also suffer more. Because of the different conditions of these patients, lack of large-scale clinical observation data, it is necessary for clinicians to make realistic decisions on the specific conditions of patients. It is a challenge for clinicians to apply the advances of modern medicine to the diagnosis and treatment of such patients so as to prolong their survival time and improve their quality of life. This report describes the survival of an advanced elderly patient with lung, prostate and bladder cancer after receiving targeted therapy-based comprehensive treatment.Keywords: advanced synchronous triple primary malignancieshttps://www.dovepress.com/clinical-treatment-of-advanced-synchronous-triple-primary-malignancies-peer-reviewed-article-OTTClinical TreatmentAdvanced Synchronous Triple Primary MalignanciesComprehensive TreatmentTargeted Therapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhang Y Ge Y Wu X Liu S |
spellingShingle |
Zhang Y Ge Y Wu X Liu S Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy OncoTargets and Therapy Clinical Treatment Advanced Synchronous Triple Primary Malignancies Comprehensive Treatment Targeted Therapy |
author_facet |
Zhang Y Ge Y Wu X Liu S |
author_sort |
Zhang Y |
title |
Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy |
title_short |
Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy |
title_full |
Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy |
title_fullStr |
Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy |
title_full_unstemmed |
Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy |
title_sort |
clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy |
publisher |
Dove Medical Press |
series |
OncoTargets and Therapy |
issn |
1178-6930 |
publishDate |
2019-04-01 |
description |
Ying Zhang, Yunjie Ge, Xiaohui Wu, Shuangmei LiuDepartment of Internal Medicine, Municipal Hospital, Qingdao, Shandong, People’s Republic of ChinaAbstract: The prevalence of cancer remains high. With the improvement of diagnosis and treatment level and the increase of cancer survivors after treatment, multiple primary tumors are more common than before. The diagnosis and treatment of synchronous multiple primary tumors is more complicated than that of single or metachronous multiple tumors, and patients also suffer more. Because of the different conditions of these patients, lack of large-scale clinical observation data, it is necessary for clinicians to make realistic decisions on the specific conditions of patients. It is a challenge for clinicians to apply the advances of modern medicine to the diagnosis and treatment of such patients so as to prolong their survival time and improve their quality of life. This report describes the survival of an advanced elderly patient with lung, prostate and bladder cancer after receiving targeted therapy-based comprehensive treatment.Keywords: advanced synchronous triple primary malignancies |
topic |
Clinical Treatment Advanced Synchronous Triple Primary Malignancies Comprehensive Treatment Targeted Therapy |
url |
https://www.dovepress.com/clinical-treatment-of-advanced-synchronous-triple-primary-malignancies-peer-reviewed-article-OTT |
work_keys_str_mv |
AT zhangy clinicaltreatmentofadvancedsynchronoustripleprimarymalignanciescomprehensivetreatmentbasedontargetedtherapy AT gey clinicaltreatmentofadvancedsynchronoustripleprimarymalignanciescomprehensivetreatmentbasedontargetedtherapy AT wux clinicaltreatmentofadvancedsynchronoustripleprimarymalignanciescomprehensivetreatmentbasedontargetedtherapy AT lius clinicaltreatmentofadvancedsynchronoustripleprimarymalignanciescomprehensivetreatmentbasedontargetedtherapy |
_version_ |
1725008991402065920 |